SEE Change Evaluation - Impacts of Personal Agency Training on Ugandan Entrepreneurs (NCT05958225) | Clinical Trial Compass
CompletedNot Applicable
SEE Change Evaluation - Impacts of Personal Agency Training on Ugandan Entrepreneurs
Uganda814 participantsStarted 2023-09-19
Plain-language summary
This study is proposed as an individually randomized control trial (RCT) designed to assess the short-term impacts (follow up at six months) of a personal agency training on a range of economic and health outcomes for micro and small entrepreneurs in Western and Central Uganda. Participants will be randomly selected and assigned to either the intervention group (n=400) or wait-listed control group (n=400). The intervention will include the standard Empowered Entrepreneur training curriculum which includes personal agency alongside basic business training that has been developed by the SEE Change team. This training will take place over three consecutive days (approximately 25 hours of content).
Who can participate
Age range
18 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Small or micro entrepreneur;
* Business has been in operation/existence for at least the past 12 months;
* Entrepreneur is between the ages of 18 and 55;
* Entrepreneur has the ability to participate in all training activities;
* Informed consent is obtained from the entrepreneur;
* The entrepreneur is not planning to leave the area in the next 12 months;
* The entrepreneur has access to a phone for contact purposes;
Exclusion Criteria:
* Entrepreneur is unable to provide informed consent or informed consent is not obtained;
* Entrepreneur is not considered a small or micro entrepreneur;
* Entrepreneur is younger than 18 years of age;
* Business has been in operation/existence for less than 12 months;
* Entrepreneur's primary business is farming (anything related to seasonal crop production);
* Entrepreneur is planning to leave the area in the next 12 months;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Business revenue and profits as assessed by questionnaire developed by study team
Timeframe: Baseline, six months
2
Change in Marketing score as assessed by questionnaire as assessed by the Micro-Enterprise survey
Timeframe: Baseline, six months
3
Change in in the number of Marketing strategies adopted as assessed by questionnaire developed by study team
Timeframe: Baseline, six months
4
Change in adoption of Business skills as assessed by questionnaire developed by study team
Timeframe: Baseline, six months
5
Change in Self-efficacy as measured by the Chen scale for self efficacy
Timeframe: Baseline, six months
6
Change in Self-esteem as measured by the Rosenberg scale
Timeframe: Baseline, six months
7
Change in ability to regulate behavior as assessed by the Short Self-Regulation Questionnaire (SSRQ)
Trial details
NCT IDNCT05958225
SponsorJohns Hopkins Bloomberg School of Public Health